Gilead Sciences Announces 2.8 Percent Increase in First Quarter 2022 Dividend Pharmaceutical Investing
Gilead Sciences Announces Fourth Quarter and Full Year 2021 Financial Results Pharmaceutical Investing
AbbVie Showcases Its Leadership in Research in Inflammatory Bowel Diseases with New Analyses to be Presented at the 17th Congress of European Crohn's and Colitis Organization Pharmaceutical Investing
Komo Plant Based Foods Achieves 200 Five-Star Customer Reviews Through Yotpo App on its eCommerce Platform Company News
U.S. FDA Approves New Label Update for CAR T-Cell Therapy Yescarta® Showing Prophylactic Steriod Use Improves Management of Cytokine Release Syndrome Pharmaceutical Investing
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory DLBCL, PMBCL and FL3B Pharmaceutical Investing
BioHarvest Sciences Inc. Projects 2022 Revenue to Grow 2.5X-3.5X to a Range of USD $5M-$7M Company News
Gilead Announces Partial Clinical Hold for Studies Evaluating Magrolimab in Combination With Azacitidine Pharmaceutical Investing
Komo Plant Based Foods to be Available for Online Purchase Across the United States through GTFO It's Vegan Company News
